$3.18
-0.16-4.79%
Pre-Market: Jan 15, 6:59 PM EDT
Dare Bioscience reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Dare Bioscience using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-14 | $-0.55 | $-0.71 | 22.5 % |
Q1 | 2024-05-14 | $-0.84 | $-0.72 | -16.7 % |
Q4 | 2024-03-28 | $-0.72 | $-1.20 | 40.0 % |
Q3 | 2023-11-09 | $-1.08 | $-1.20 | 10.0 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-14 | $41.69K | $2.02M | -97.9 % |
Q2 | 2024-08-12 | $22.44M | $5.89M | 280.9 % |
Q1 | 2024-05-14 | $9.30M | $260.00K | 3477.7 % |
Q4 | 2024-03-28 | $1.81M | $1.79M | 1.01 % |
Dare Bioscience (DARE) is scheduled to report earnings on March 27, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
The Actual EPS was $-0.55, which beat the estimate of $-0.71.
The Actual Revenue was $41.7K, which missed the estimate of $2M.
Browse earnings estimates, EPS, and revenue on all stocks.